Koichi Goto Selected Research

Fever (Fevers)

1/2022	Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001.
2/2004	Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Goto Research Topics

Disease

116	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2002
104	Neoplasms (Cancer) 05/2024 - 01/2002
33	Lung Neoplasms (Lung Cancer) 04/2024 - 02/2004
23	Adenocarcinoma of Lung 12/2023 - 04/2002
22	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2023 - 12/2006
10	Adenocarcinoma 02/2024 - 11/2004
10	Disease Progression 11/2023 - 01/2013
10	Neoplasm Metastasis (Metastasis) 11/2023 - 03/2006
9	Carcinoma (Carcinomatosis) 11/2019 - 04/2002
7	Diarrhea 01/2023 - 12/2010
7	Neutropenia 01/2020 - 07/2004
6	Hypertension (High Blood Pressure) 12/2022 - 05/2010
6	Febrile Neutropenia 01/2020 - 10/2015
6	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015 - 09/2010
5	Exanthema (Rash) 01/2023 - 09/2013
4	Nausea 10/2020 - 12/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 06/2012
4	Thymoma (Thymic Carcinoma) 07/2015 - 09/2003
3	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2015
3	Necrosis 01/2021 - 07/2019
3	Vomiting 10/2020 - 01/2018
3	Anorexia 01/2020 - 01/2016
3	Radiation Pneumonitis 01/2020 - 06/2008
3	Colonic Neoplasms (Colon Cancer) 12/2019 - 01/2011
3	Brain Neoplasms (Brain Tumor) 11/2018 - 03/2006
3	Breast Neoplasms (Breast Cancer) 07/2009 - 03/2004
2	Hypersensitivity (Allergy) 01/2024 - 01/2022
2	Pneumonia (Pneumonitis) 02/2023 - 08/2016
2	Fever (Fevers) 01/2022 - 02/2004
2	Hyponatremia 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

35	Tyrosine Kinase InhibitorsIBA 01/2024 - 12/2008
30	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2006
25	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2002
17	PlatinumIBA 04/2022 - 07/2003
14	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2023 - 09/2013
12	Gefitinib (Iressa)FDA Link 01/2023 - 11/2004
12	Liposomes (Liposome)IBA 06/2013 - 04/2002
11	Docetaxel (Taxotere)FDA Link 09/2019 - 02/2002
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2004
10	Bevacizumab (Avastin)FDA Link 06/2023 - 10/2010
10	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2007
9	CrizotinibIBA 05/2024 - 01/2017
9	NivolumabIBA 02/2023 - 01/2016
9	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 04/2004
9	Dimyristoylphosphatidylcholine (DMPC)IBA 06/2013 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2013
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2008
8	Pemetrexed (MTA)FDA Link 04/2021 - 12/2015
7	Phosphotransferases (Kinase)IBA 05/2024 - 12/2015
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2002
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
7	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2013 - 09/2004
6	selpercatinibIBA 11/2023 - 01/2020
6	alectinibIBA 11/2023 - 01/2017
6	osimertinibIBA 12/2021 - 11/2019
6	vandetanib (ZD6474)IBA 01/2021 - 07/2013
6	Therapeutic UsesIBA 02/2015 - 01/2011
5	Anaplastic Lymphoma KinaseIBA 11/2023 - 11/2013
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 10/2018
5	Alanine Transaminase (SGPT)IBA 01/2023 - 10/2018
5	Cadherins (E-Cadherin)IBA 01/2021 - 06/2012
5	AfatinibIBA 01/2021 - 09/2013
4	entrectinibIBA 12/2023 - 01/2020
4	NucleotidesIBA 11/2023 - 05/2018
4	brigatinibIBA 09/2023 - 12/2022
4	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 09/2003
4	pembrolizumabIBA 04/2021 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 10/2007
3	Adenosine Triphosphate (ATP)IBA 05/2024 - 03/2004
3	EnzymesIBA 09/2023 - 07/2007
3	Formaldehyde (Formol)FDA Link 01/2021 - 03/2004
3	AntiemeticsIBA 10/2020 - 01/2018
3	Monoclonal AntibodiesIBA 01/2020 - 10/2010
3	ezrinIBA 11/2017 - 07/2015
3	amrubicinIBA 01/2017 - 09/2010
3	Docosahexaenoic AcidsIBA 01/2011 - 03/2008
3	MicellesIBA 12/2010 - 07/2009
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2009 - 03/2004
3	Polysorbates (PSML)FDA Link 07/2008 - 04/2002
2	lorlatinibIBA 04/2024 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 08/2023 - 07/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023 - 07/2009
2	TAS6417IBA 03/2023 - 11/2019
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	atezolizumabIBA 07/2021 - 04/2021
2	ParaffinIBA 01/2021 - 12/2008

Therapy/Procedure

53	Drug Therapy (Chemotherapy) 02/2023 - 07/2003
40	Therapeutics 09/2023 - 03/2006
13	Radiotherapy 10/2023 - 03/2005
10	Chemoradiotherapy 01/2020 - 06/2008
7	Combination Drug Therapy (Combination Chemotherapy) 07/2019 - 07/2003
5	Precision Medicine 04/2024 - 07/2020
3	Palliative Care (Palliative Therapy) 04/2022 - 01/2017
3	Proton Therapy 01/2020 - 01/2016
3	Induction Chemotherapy 01/2017 - 03/2005
3	Aftercare (After-Treatment) 02/2015 - 07/2009
2	Immunotherapy 04/2021 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 07/2019
2	Surgical Instruments (Clip) 01/2021 - 07/2020